European Medicines Agency Begins Review Of Heart Risks From Common Pain Killers

[News Reporter]

The European Medicines Agency (EMA) is beginning a through analysis of the latest data on the cardiovascular risks from non-selective NSAIDS (non-steroidal anti-inflammatory drugs), that are primarily used as pain killers. The case of Vioxx is well documented and lesser issues such as gastrointestinal irritation from Asprin are also well known. NSAIDS have been the subject of several European reviews in relation to safety and side effects...

More...